(Q42182185)

18 October 2017

title

Artesunate inhibits proliferation of naïve CD4(+) T cells but enhances function of effector T cells (English)

1 reference

18 October 2017

0 references

Sung Ho Lee

1

1 reference

18 October 2017

Young-Chang Cho

2

1 reference

18 October 2017

Kyung Hee Kim

3

1 reference

18 October 2017

Ik-Soo Lee

4

1 reference

18 October 2017

Hyun Jin Choi

5

1 reference

18 October 2017

Bok Yun Kang

6

1 reference

18 October 2017

publication date

6 November 2014

1 reference

Archives of Pharmacal Research

18 October 2017

published in

1 reference

18 October 2017

volume

38

1 reference

18 October 2017

issue

6

1 reference

18 October 2017

page(s)

1195-1203

1 reference

Functional diversity of helper T lymphocytes

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Malaria and artemisinin derivatives: an updated review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

The concept of type-1 and type-2 helper T cells and their cytokines in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

The antiviral activities of artemisinin and artesunate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Overview of interleukin-2 function, production and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Pharmacokinetics and pharmacodynamics of endoperoxide antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

The role of B7 costimulation in T-cell immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Artesunate activates Nrf2 pathway-driven anti-inflammatory potential through ERK signaling in microglial BV2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Evaluation of the immunosuppressive activity of artesunate in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Role of T-bet in commitment of TH1 cells before IL-12-dependent selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Artemisinin drugs: novel antimalarial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Dihydroartemisinin suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Apoptosis of human umbilical vein endothelial cells induced by artesunate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Dihydroartemisinin ameliorates inflammatory disease by its reciprocal effects on Th and regulatory T cell function via modulating the mammalian target of rapamycin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

A novel artemisinin derivative, 3-(12-beta-artemisininoxy) phenoxyl succinic acid (SM735), mediates immunosuppressive effects in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

Evidence for the Involvement of Carbon-centered Radicals in the Induction of Apoptotic Cell Death by Artemisinin Compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-014-0491-5

10.1007/S12272-014-0491-5

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

18 October 2017

1047843694

0 references

1 reference